首页|右美托咪定在单孔胸腔镜肺癌根治术中的应用效果分析

右美托咪定在单孔胸腔镜肺癌根治术中的应用效果分析

扫码查看
目的 分析右美托咪定在单孔胸腔镜肺癌根治术中的应用效果.方法 选取 100 例行单孔胸腔镜肺癌根治术的患者,根据术中麻醉用药情况分为对照组(未使用右美托咪定)和实验组(使用右美托咪定),每组 50 例.对照组术中使用瑞芬太尼复合七氟烷麻醉,实验组术中使用右美托咪定、瑞芬太尼复合七氟烷麻醉.比较两组患者术前到术后共 11 个时间点血压、心率的波动情况,苏醒情况,术前、术后空腹血糖变化情况;观察两组患者并发症发生情况及追加药物情况.结果 ①与本组术前(T1)比较,两组患者麻醉开始前(T2)收缩压显著升高(P<0.05).②两组患者术后第 1 天(T11)舒张压低于本组 T1 时(P<0.05).③麻醉开始后 60 min(T4),实验组患者心率低于对照组(P<0.05).④两组患者拔管时间、拔管后苏醒时间、总苏醒时间比较均无显著差异(P>0.05).两组患者在麻醉后监测治疗室(PACU)的Steward 评分均达到 6 分,安全送返普通病房.⑤两组术前、术后空腹血糖及血糖变化差值组间比较无显著差异(P>0.05);两组术后空腹血糖均高于本组术前(P<0.05).⑥两组患者术后在 PACU 苏醒期间均无严重并发症发生,均未发生患者 PACU 停留时间>2 h 情况.结论 右美托咪定、瑞芬太尼复合七氟烷麻醉在单孔胸腔镜肺癌根治术中应用可以降低患者术中心率,其余循环指标、苏醒质量无显著差异,术后血糖较术前显著增高,但与瑞芬太尼复合七氟烷麻醉无显著差异.
Comparison of practical effects of dexmedetomidine in single-port thoracoscopic radical resection of lung cancer
Objective To analyze the practical effects of dexmedetomidine in single-port thoracoscopic radical resection of lung cancer.Methods A total of 100 patients who underwent single-port thoracoscopic radical resection of lung cancer were selected and divided into the control group(without dexmedetomidine)and the experimental group(with dexmedetomidine)according to the intraoperative anesthesia,with 50 cases in each group.The control group was anesthetized with remifentanil combined with sevoflurane,while the experimental group was anesthetized with dexmedetomidine and remifentanil combined with sevoflurane.The variations of blood pressure and heart rate at 11 time points from preoperative to postoperative,recovery conditions and the changes of fasting blood glucose before and after surgery were compared between the two groups.The occurrence of complications and the use of additional drugs in the two groups were observed.Results a.Compared with the day before surgery(T1)of the same group,the systolic blood pressure before anesthesia(T2)was significantly increased for the two groups(P<0.05).b.On the first day after surgery(T11),the diastolic blood pressure of the two groups of patients was lower than that of this group at T1(P<0.05).c.At 60 min after anesthesia(T4),the heart rate of the patients in the experimental group was lower than that in the control group(P<0.05).d.There were no significant differences in extubation time,recovery time after extubation and total recovery time between the two groups(P>0.05).The Steward score of both groups reached 6 points in the post-anesthesia care unit(PACU),and the patients were safely returned to the general ward.e.There were no significant differences in the changes of fasting blood glucose before and after surgery between the two groups(P>0.05).The fasting blood glucose after surgery in both groups was higher than that before surgery(P<0.05).f.There were no serious complications during recovery in PACU in both groups after surgery,and there was no case that PACU stayed for more than 2 hours.Conclusion The application of dexmedetomidine combined with remifentanil and sevoflurane anesthesia in single-port thoracoscopic radical resection of lung cancer can reduce the heart rate of patients during the operations,and there is no significant difference in the other circulation indications,the quality of anesthesia resuscitation and the postoperative blood glucose is significantly higher than that before surgery,but there is no significant difference with remifentanil combined sevoflurane anesthesia.

DexmedetomidineSingle-port thoracoscopic radical resection of lung cancerStress responseHemodynamic changesQuality of anesthesia resuscitation

于霜霜、祖明龙、徐诺、张林、朱映锟、韩玉湘

展开 >

519099 中山大学附属第五医院

右美托咪定 单孔胸腔镜肺癌根治术 应激反应 血流动力学变化 苏醒质量

2024

中国实用医药
中国康复医学会

中国实用医药

影响因子:0.797
ISSN:1673-7555
年,卷(期):2024.19(7)
  • 17